financetom
Business
financetom
/
Business
/
Update On Cenovus 2025 Budget; National Bank With First Look
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update On Cenovus 2025 Budget; National Bank With First Look
Dec 12, 2024 8:14 AM

10:58 AM EST, 12/12/2024 (MT Newswires) -- (Adds National Bank commentary in sixth paragraph)

Cenovus Energy ( CVE ) on Thursday released its 2025 corporate guidance that envisions $4.6 billion to $5 billion in capital spending.

The company expects to deliver upstream production of 805,000 barrels of oil equivalent per day (boe/d) to 845,000 boe/d, a 4% increase from 2024 levels, and downstream crude unit utilization of 90% to 95%.

Capital spending will include about $3.2 billion of sustaining capital. An additional $1.4 billion to $1.8 billion will be used to advance upstream growth projects.

General and administrative costs are expected to remain flat relative to 2024.

"Cenovus will deliver important milestones on our major growth projects in 2025, including achieving first oil from Narrows Lake, installation of the West White Rose offshore facilities and commencement of drilling, and preparations for first steam at the Foster Creek optimization project," Cenovus President and CEO Jon McKenzie said.

Cenovus kept its Outperform rating and $31 price target at National Bank of Canada in the bank's first look at the news. The price target is based on a 2025 6.0x EV/DACF multiple.

The bank said overall Cenovus' capital spending and production guidance is largely in line with both its estimates and street forecasts.

National Bank is currently forecasting 2025 free cash flow (FCF) of near $3.9 billion on a payout ratio of 61%. The bank will be publishing its revised estimates in tandem with its 2025 Outlook next week.

Cenovus' share price was down more than 1% at last look to $21.48 on the TSX.

Price: 21.48, Change: -0.23, Percent Change: -1.06

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Report of TSMC chips made for Huawei
Report of TSMC chips made for Huawei "a huge concern", US Commerce nominee says
Feb 27, 2025
(Reuters) - U.S. President Donald Trump's nominee to a post overseeing export policy for China on Thursday called a report about Taiwan Semiconductor Manufacturing Co ( TSM ) producing hundreds of thousands of chips for Huawei a huge concern. Jeffrey Kessler, Trump's pick for Under Secretary of Commerce for Industry and Security, was asked at his nomination hearing before the...
Update: Veren Shares Up 10% as It Posts Higher Q4 Earnings and Revenue but Misses Forecasts
Update: Veren Shares Up 10% as It Posts Higher Q4 Earnings and Revenue but Misses Forecasts
Feb 27, 2025
11:56 AM EST, 02/27/2025 (MT Newswires) -- (Updates shares.) Veren ( VRN ) at last look surged 10% on the TSX despite the company's adjusted earnings missing analyst estimates in the fourth quarter of 2024. The Western Canadian oil and gas producer reported adjusted earnings, excluding most one-time items, of $247.0 million, or $0.40 per share, up from $192.8 million,...
US Consumer Financial Protection Bureau Reportedly Drops Lawsuit Against Capital One Financial
US Consumer Financial Protection Bureau Reportedly Drops Lawsuit Against Capital One Financial
Feb 27, 2025
11:57 AM EST, 02/27/2025 (MT Newswires) -- The US Consumer Financial Protection Bureau has dropped a lawsuit against Capital One Financial ( COF ) , multiple media outlets reported Thursday. The agency in January had accused the bank holding company of cheating millions of consumers over $2 billion in interest payments on savings accounts. In legal filings, the agency issued...
PDS Biotechnology Launches Registered Direct Offering; Shares Up
PDS Biotechnology Launches Registered Direct Offering; Shares Up
Feb 27, 2025
11:55 AM EST, 02/27/2025 (MT Newswires) -- PDS Biotechnology ( PDSB ) said Thursday it is selling about 7.3 million common shares and warrants to purchase up to about 7.3 million common shares in a registered direct offering at a combined purchase price of $1.50 for institutional investors and $1.66 for certain PDS Biotechnology ( PDSB ) directors. The company...
Copyright 2023-2025 - www.financetom.com All Rights Reserved